Xcout Intel
VitriVax competitors & alternatives
The 12 closest competitors and alternatives to VitriVax among biotechnology companies — ranked by similarity to what VitriVax actually does, not by market-cap band.
Subscribe to see VitriVax’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About VitriVax
VitriVax, Inc. is a biotechnology company headquartered in Boulder, Colorado, dedicated to eliminating barriers to global vaccination. The company develops innovative vaccine formulation and stabilization technologies.
VitriVax at a glance
VitriVax is a biotechnology company headquartered in United States. It has raised at least $46.7M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $17.3M in October 2025. Xcout tracks 10 named people at VitriVax, including Louise Brady (Chief Executive Officer).
VitriVax leadership
- Louise BradyChief Executive Officer
- Romulo ColindresPresident/CEO
- Rene LorenzCO-FOUNDER
- Theodore RandolphCo-Founder
- Romulo ColindresExecutive Officer
- Louise BradyDirector
4 more named people on record for VitriVax, with roles, board committees and tenure — see the full roster →
VitriVax funding rounds
At least $46.7M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $17.3M | 4 named | |
| SEC Form D filing | $29.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 VitriVax competitors
Ranked by semantic similarity — how close each company is to VitriVax by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
GlobeImmune, Inc. is a clinical-stage biopharmaceutical company headquartered in Louisville, Colorado, focused on developing therapeutic vaccines to treat cancer and infectious diseases.
Similar biotechnology company
Mosaic Biosciences, Inc. is a biotechnology company based in Boulder, Colorado. The firm operates research and corporate facilities to support scientific discovery and development.
Similar biotechnology company
Vaxxas is a clinical-stage biotechnology company headquartered in Brisbane, Australia. It is commercializing a novel vaccination technology designed to enhance the performance of existing and next-generation vaccines, and opened a biomedical manufacturing facility in Brisbane in June 2023.
Similar biotechnology company
MalarVx, Inc. is a clinical-stage biopharmaceutical vaccine company located in Seattle, Washington, founded to develop innovative vaccines addressing global infectious diseases.
Biotech
GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform. Its product pipeline includes several prophylactic vaccines aimed at preventing illnesses such as COVID-19, human immunodeficiency virus (HIV), Zika virus, malaria, and a range of hemorrhagic fevers like Ebola, Sudan, Marburg, and Lassa. Additionally, GeoVax is developing therapeutic vaccines designed to treat existing conditions, specifically HIV, chronic Hepatitis B infections, and solid tumor cancers. To support its research and development efforts, GeoVax Labs, Inc. has forged partnerships with notable organizations. These collaborators include the National Institute of Allergy and Infectious Diseases (part of the National Institutes of Health), the Centers for Disease Control and Prevention, the U.S. Department of Defense, Emory University, the University of Pittsburgh, and the Burnet Institute. Founded in 1988, GeoVax Labs, Inc. is headquartered in Smyrna, Georgia.
Biotech
Enveda Biosciences (Enveda Therapeutics Inc.) is a biotechnology research company headquartered in Boulder, Colorado. The company leverages artificial intelligence to discover novel therapeutics and chemical compounds derived from natural sources.
Biotech
Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Its development programs for oral vaccine delivery include prophylactic, enteric-coated tablet vaccines for inhibiting norovirus, seasonal influenza, respiratory syncytial virus, and human papillomavirus. It was founded in 2004 by Sean Tucker. Originally incorporated as West Coast Biologicals, Inc. in California in
Similar biotechnology company
Affinivax, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, that pioneered a novel class of multiplex vaccine technologies.
Similar biotechnology company
Curevo, Inc. is a biopharmaceutical company headquartered in Bothell, Washington. The company is focused on the research and clinical development of innovative vaccine technologies.
Similar biotechnology company
BlueWillow Biologics is a clinical-stage, privately held biopharmaceutical company headquartered in Ann Arbor, Michigan. The company pioneers the future of intranasal vaccines and utilizes a proprietary nanoemulsion adjuvant delivery platform.
Similar biotechnology company
Calder Biosciences Inc. is a nano-scale molecular engineering company founded in 2018 that develops next-generation conformationally-stabilized universal influenza vaccines and other biologics.
Similar biotechnology company
Crestone is a clinical-stage biopharmaceutical and biotechnology company headquartered in Boulder, Colorado. The company focuses on the research and development of novel small-molecule drugs targeting serious bacterial infections such as C. diff.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of VitriVax and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for VitriVaxand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →